US Stock MarketDetailed Quotes

GRTX Galera Therapeutics

Watchlist
  • 0.145
  • -0.070-32.59%
Close Jun 3 16:00 ET
  • 0.138
  • -0.007-4.83%
Post 19:56 ET
7.89MMarket Cap-159P/E (TTM)

Galera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
58.93%-4.79M
-3.27%-44.85M
28.90%-9.92M
-35.95%-12.52M
-20.93%-10.75M
-2.47%-11.67M
36.10%-43.43M
20.07%-13.95M
49.96%-9.21M
47.12%-8.89M
Net income from continuing operations
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
34.97%-14.56M
Operating gains losses
----
---72K
--0
--0
----
----
----
----
----
----
Depreciation and amortization
-55.00%9K
127.19%259K
726.92%215K
-55.56%12K
-60.00%12K
-35.48%20K
-85.35%114K
-94.40%26K
-74.53%27K
-70.59%30K
Deferred tax
----
--0
----
----
----
----
---70K
----
----
----
Other non cash items
----
-1.36%11.41M
-78.79%705K
-35.69%2.09M
62.99%4.4M
83.37%4.22M
60.84%11.57M
43.77%3.32M
39.45%3.25M
107.30%2.7M
Change In working capital
-477.26%-1.29M
-17,317.65%-2.93M
-132.06%-6.44M
-152.03%-937K
268.55%4.1M
376.61%343K
100.65%17K
48.40%-2.77M
2,323.46%1.8M
-56.63%1.11M
-Change in receivables
----
200.00%3.24M
--0
--0
----
----
---3.24M
---3.24M
--0
----
-Change in prepaid assets
270.40%1.65M
-79.68%514K
60.01%-619K
-66.30%365K
-71.95%322K
-75.84%446K
347.46%2.53M
29.41%-1.55M
26.67%1.08M
-39.07%1.15M
-Change in payables and accrued expense
-4,171.01%-2.95M
-1,393.47%-8.51M
-523.57%-7.68M
-240.20%-994K
94.02%227K
96.52%-69K
162.55%658K
169.13%1.81M
159.93%709K
-87.32%117K
-Change in other current assets
280.00%38K
485.45%1.93M
601.85%1.9M
-477.78%-272K
432.22%299K
-87.18%10K
234.15%330K
206.72%270K
-70.85%72K
63.11%-90K
-Change in other current liabilities
15.91%-37K
59.69%-104K
44.62%-36K
42.86%-36K
119.35%12K
35.29%-44K
15.96%-258K
78.83%-65K
---63K
-2,166.67%-62K
Cash from discontinued investing activities
Operating cash flow
58.93%-4.79M
-3.27%-44.85M
28.90%-9.92M
-35.95%-12.52M
-20.93%-10.75M
-2.47%-11.67M
36.10%-43.43M
20.07%-13.95M
49.96%-9.21M
47.12%-8.89M
Investing cash flow
Cash flow from continuing investing activities
0
13.75%27.29M
43.04%3.98M
127.28%10.46M
14.12%7.55M
-46.93%5.31M
358.08%23.99M
-85.86%2.78M
110.70%4.6M
-57.99%6.62M
Net PPE purchase and sale
----
-136.00%-59K
---9K
--0
----
----
91.17%-25K
--0
80.00%-5K
63.16%-7K
Net investment purchase and sale
--0
13.88%27.35M
43.36%3.98M
127.03%10.46M
14.75%7.6M
-47.00%5.31M
335.05%24.02M
-85.90%2.78M
110.71%4.61M
-57.99%6.62M
Cash from discontinued investing activities
Investing cash flow
--0
13.75%27.29M
43.04%3.98M
127.28%10.46M
14.12%7.55M
-46.93%5.31M
358.08%23.99M
-85.86%2.78M
110.70%4.6M
-57.99%6.62M
Financing cash flow
Cash flow from continuing financing activities
0
709.87%31.5M
-108.59%-232K
21,240.00%2.13M
90,500.00%1.81M
2,264.43%27.78M
-94.17%3.89M
12,181.82%2.7M
-99.98%10K
-99.99%2K
Net common stock issuance
--0
669.41%29.3M
-108.62%-232K
--1.93M
--0
2,370.73%27.6M
-52.05%3.81M
134,450.00%2.69M
--0
--0
Proceeds from stock option exercised by employees
--0
2,612.35%2.2M
--0
1,910.00%201K
90,500.00%1.81M
217.24%184K
-93.60%81K
-45.00%11K
-98.88%10K
-98.33%2K
Cash from discontinued financing activities
Financing cash flow
--0
709.87%31.5M
-108.59%-232K
21,240.00%2.13M
90,500.00%1.81M
2,264.43%27.78M
-94.17%3.89M
12,181.82%2.7M
-99.98%10K
-99.99%2K
Net cash flow
Beginning cash position
323.01%18.26M
-78.27%4.32M
91.15%24.43M
40.15%24.35M
31.01%25.74M
-78.27%4.32M
25.12%19.86M
-27.52%12.78M
-54.83%17.38M
43.53%19.65M
Current changes in cash
-122.37%-4.79M
189.69%13.94M
27.08%-6.17M
101.68%77K
38.96%-1.39M
10,109.81%21.42M
-489.84%-15.54M
-480.06%-8.46M
77.94%-4.6M
-109.16%-2.27M
End cash Position
-47.68%13.47M
323.01%18.26M
323.01%18.26M
91.15%24.43M
40.15%24.35M
31.01%25.74M
-78.27%4.32M
-78.27%4.32M
-27.52%12.78M
-54.83%17.38M
Free cash flow
58.93%-4.79M
-3.35%-44.91M
28.83%-9.92M
-35.88%-12.52M
-21.40%-10.8M
-2.35%-11.67M
36.33%-43.45M
20.31%-13.95M
50.00%-9.22M
47.14%-8.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 58.93%-4.79M-3.27%-44.85M28.90%-9.92M-35.95%-12.52M-20.93%-10.75M-2.47%-11.67M36.10%-43.43M20.07%-13.95M49.96%-9.21M47.12%-8.89M
Net income from continuing operations 75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M34.97%-14.56M
Operating gains losses -------72K--0--0------------------------
Depreciation and amortization -55.00%9K127.19%259K726.92%215K-55.56%12K-60.00%12K-35.48%20K-85.35%114K-94.40%26K-74.53%27K-70.59%30K
Deferred tax ------0-------------------70K------------
Other non cash items -----1.36%11.41M-78.79%705K-35.69%2.09M62.99%4.4M83.37%4.22M60.84%11.57M43.77%3.32M39.45%3.25M107.30%2.7M
Change In working capital -477.26%-1.29M-17,317.65%-2.93M-132.06%-6.44M-152.03%-937K268.55%4.1M376.61%343K100.65%17K48.40%-2.77M2,323.46%1.8M-56.63%1.11M
-Change in receivables ----200.00%3.24M--0--0-----------3.24M---3.24M--0----
-Change in prepaid assets 270.40%1.65M-79.68%514K60.01%-619K-66.30%365K-71.95%322K-75.84%446K347.46%2.53M29.41%-1.55M26.67%1.08M-39.07%1.15M
-Change in payables and accrued expense -4,171.01%-2.95M-1,393.47%-8.51M-523.57%-7.68M-240.20%-994K94.02%227K96.52%-69K162.55%658K169.13%1.81M159.93%709K-87.32%117K
-Change in other current assets 280.00%38K485.45%1.93M601.85%1.9M-477.78%-272K432.22%299K-87.18%10K234.15%330K206.72%270K-70.85%72K63.11%-90K
-Change in other current liabilities 15.91%-37K59.69%-104K44.62%-36K42.86%-36K119.35%12K35.29%-44K15.96%-258K78.83%-65K---63K-2,166.67%-62K
Cash from discontinued investing activities
Operating cash flow 58.93%-4.79M-3.27%-44.85M28.90%-9.92M-35.95%-12.52M-20.93%-10.75M-2.47%-11.67M36.10%-43.43M20.07%-13.95M49.96%-9.21M47.12%-8.89M
Investing cash flow
Cash flow from continuing investing activities 013.75%27.29M43.04%3.98M127.28%10.46M14.12%7.55M-46.93%5.31M358.08%23.99M-85.86%2.78M110.70%4.6M-57.99%6.62M
Net PPE purchase and sale -----136.00%-59K---9K--0--------91.17%-25K--080.00%-5K63.16%-7K
Net investment purchase and sale --013.88%27.35M43.36%3.98M127.03%10.46M14.75%7.6M-47.00%5.31M335.05%24.02M-85.90%2.78M110.71%4.61M-57.99%6.62M
Cash from discontinued investing activities
Investing cash flow --013.75%27.29M43.04%3.98M127.28%10.46M14.12%7.55M-46.93%5.31M358.08%23.99M-85.86%2.78M110.70%4.6M-57.99%6.62M
Financing cash flow
Cash flow from continuing financing activities 0709.87%31.5M-108.59%-232K21,240.00%2.13M90,500.00%1.81M2,264.43%27.78M-94.17%3.89M12,181.82%2.7M-99.98%10K-99.99%2K
Net common stock issuance --0669.41%29.3M-108.62%-232K--1.93M--02,370.73%27.6M-52.05%3.81M134,450.00%2.69M--0--0
Proceeds from stock option exercised by employees --02,612.35%2.2M--01,910.00%201K90,500.00%1.81M217.24%184K-93.60%81K-45.00%11K-98.88%10K-98.33%2K
Cash from discontinued financing activities
Financing cash flow --0709.87%31.5M-108.59%-232K21,240.00%2.13M90,500.00%1.81M2,264.43%27.78M-94.17%3.89M12,181.82%2.7M-99.98%10K-99.99%2K
Net cash flow
Beginning cash position 323.01%18.26M-78.27%4.32M91.15%24.43M40.15%24.35M31.01%25.74M-78.27%4.32M25.12%19.86M-27.52%12.78M-54.83%17.38M43.53%19.65M
Current changes in cash -122.37%-4.79M189.69%13.94M27.08%-6.17M101.68%77K38.96%-1.39M10,109.81%21.42M-489.84%-15.54M-480.06%-8.46M77.94%-4.6M-109.16%-2.27M
End cash Position -47.68%13.47M323.01%18.26M323.01%18.26M91.15%24.43M40.15%24.35M31.01%25.74M-78.27%4.32M-78.27%4.32M-27.52%12.78M-54.83%17.38M
Free cash flow 58.93%-4.79M-3.35%-44.91M28.83%-9.92M-35.88%-12.52M-21.40%-10.8M-2.35%-11.67M36.33%-43.45M20.31%-13.95M50.00%-9.22M47.14%-8.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg